Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Journal of the American Academy of Dermatology|September 23, 2014
A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasisKenneth B Gordon, Craig L Leonardi, Mark Lebwohl, et al.The Canadian Journal of Cardiology|December 6, 2014
Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery diseaseBasem Elbarouni, Warren J Cantor, John Ducas, et al.The Canadian Journal of Cardiology|June 28, 2006
Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithmDavid H Fitchett, Bjug Borgundvaag, Warren Cantor, et al.Spine Deformity|January 21, 2019
Improving Complex Pediatric and Adult Spine Care While Embracing the Value EquationRajiv K Sethi, Vijay Yanamadala, Suken A Shah, et al.American Heart Journal|February 7, 2012
Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trialShahar Lavi, Warren J Cantor, Amparo Casanova, et al.Journal of the American Academy of Dermatology|October 3, 2006
Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension studyKenneth B Gordon, Richard G Langley, Craig Leonardi, et al.American Heart Journal|December 18, 2007
Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)Warren J Cantor, David Fitchett, Bjug Borgundvaag, et al.Heart (British Cardiac Society)|January 23, 2014
Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trialJuan J Russo, Shaun G Goodman, Warren J Cantor, et al.Nature Genetics|November 11, 2003
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasisCynthia Helms, Li Cao, James G Krueger, et al.The Canadian Journal of Cardiology|November 15, 2006
Transfer for urgent percutaneous coronary intervention early after thrombolysis for ST-elevation myocardial infarction: the TRANSFER-AMI pilot feasibility studyWarren J Cantor, Jason Burnstein, Richard Choi, et al.Pageof 4